Covenant Asset Management, LLC United Therapeutics Corp Transaction History

Covenant Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$212.99 - $276.17 $29,392 - $38,111	-138 Reduced 0.98%	14,010 $3.14 Million
Q4 2022 Jan 24, 2023	SELL	$205.95 - $280.43 $30,892 - $42,064	-150 Reduced 1.05%	14,148 $0
Q3 2022 Nov 03, 2022	BUY	$203.3 - $244.17 $1.51 Million - $1.81 Million	7,408 Added 107.52%	14,298 $2.99 Million
Q2 2022 Jul 21, 2022	BUY	$174.81 - $241.14 $1.2 Million - $1.66 Million	6,890 New	6,890 $1.62 Million

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Covenant Asset Management, LLC with notifications on news.